ASCO Abstracts ASCO: Lisocabtagene maraleucel (liso-cel) Abstract No : 8040 Indication : Non-Hodgkin's Lymphoma (aggressive) Intervention : Lisocabtagene maraleucel Company : Juno Therapeutics, a Bristol-Myers...
ASCO abstracts 2020
ASCO Abstracts ASCO: Phase III QUAZAR AML-001 trial Abstract No : 7530 Abstract Type : Poster Discussion Session Indication : Acute...